IncFact
Company Profiles: Revenue, Growth, Competition

Impel Pharmaceuticals Revenue, Growth & Competitor Profile

DBA IMPEL BIOPHARMACEUTICALS
DBA IMPEL NEUROPHARMA INC
Last updated:

Company Awards

Fast Growing
Fastest Growing
Big Fish
Big Fish
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Impel Pharmaceuticals

Access the complete profile.

Impel Pharmaceuticals Fast Facts

Revenue$100 - $500 million    See Exact Annual Revenue
Employees100 - 500Exact Company Size
Primary Industry325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes325412 Pharmaceutical Preparation Manufacturing
5417 Scientific Research & Development Services
Address201 Elliott Ave W Ste 260
Seattle, WA 98119

Note: Revenues for privately held companies are statistical evaluations.


Impel Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?
    • Impel Pharmaceuticals is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Impel Pharmaceuticals Annual Revenue and Growth Rate

Impel Pharmaceuticals Revenue Est.
($ Million)
Growth Rate (%)# Employees
2023 $100 - $500 million

Details in Premium Report
2022
2021
2020
2019


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Impel Pharmaceuticals's revenues are gauged from an analysis of company filings.



Impel Pharmaceuticals's Income Statement (based on Industry Averages)

Impel Pharmaceuticals P&L$ Millions
Revenue (Sales) Impel Pharmaceuticals Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Trademark Applications

Trademark applications show the products and services that Impel Pharmaceuticals is developing and marketing. Impel Pharmaceuticals doesn't have any recent trademark applications, indicating Impel Pharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
TRUDHESA
Pharmaceutical preparations for the treatment and alleviation of migraine headaches
08/14/2019
TULIFTA
Pharmaceutical preparations for the treatment and alleviation of migraine headaches
08/14/2019

See all trademarks and details in the Full Report.


Market Share of Impel Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Impel Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
XYMOGENOrlando, FL100 
AVANTI NUTRITIONAL LABORATORIESMiami Lakes, FL37 
NUTRITION FORMULATORSMiramar, FL36 
RTPRCabot, AR33 
INTEGRATED BOTANICSFort Worth, TX29 
COSMAX NBT USAGarland, TX29 
CJB INDUSTRIESValdosta, GA28 
ALTERNATIVE LABORATORIESNaples, FL28 
S&B PHARMAAzusa, CA28 




Nearby Competitors

These companies are similar in business line and location to Impel Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
JUST-EVOTEC BIOLOGICSSeattle, WA100 
IMPEL PHARMACEUTICALSSeattle, WA61 
TILRAYSeattle, WA48 
UMOJA BIOPHARMASeattle, WA32 
ZYMEWORKS BIOPHARMACEUTICALSSeattle, WA21 
APTEVO THERAPEUTICSeattle, WA11 




Future Competition: Impel Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Impel Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Impel Pharmaceuticals Competitors